compounded semaglutide crackdown news november 2025 Hims & Hers Health addresses scrutiny of GLP-1 compounding| STAT The FDA announced plans to

Additionally, evaluating how these therapies interact with current antidiabetic treatments and determining their suitability for combination therapies may further enhance their clinical value

A Phase 2 substudy showed 26.1% fat mass reduction with limited lean mass loss

The active pharmaceutical ingredient is the same

Retatrutide Dosage: What We Know So Far Although dosing may evolve in later trials, current study protocols include: Weekly injectable doses starting at 1 mg or 2 mg Gradual titration over several months Higher doses such as 8 mg and 12 mg producing the most significant weight loss results The long titration schedule is designed to improve tolerability, similar to semaglutide and tirzepatide protocols